Anti-3-[18F]FACBC is further mediated not only via leucine preferring transport system L (LAT1), like the above mentioned tracers, but also via alanine-serine-cysteine transporter 2 (ASCT2) which is commonly upregulated in cancer cells [16, 21, 22]. The gene discussed is SLC1A5; the disease is cancer.